Nancy Thornberry is Director of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 2,035 shares of VRTX, which is worth approximately $916,299. The most recent transaction as insider was on May 01, 2025, when has been sold 398 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.04K
24.31% 3M change
24.31% 12M change
Total Value Held $916,299

Nancy Thornberry Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2025
BUY
Grant, award, or other acquisition
-
398 Added 16.36%
2,035 Common Stock
May 01 2024
BUY
Grant, award, or other acquisition
-
501 Added 23.43%
1,637 Common Stock
Dec 05 2023
BUY
Grant, award, or other acquisition
-
1,136 Added 50.0%
1,136 Common Stock

Also insider at

DNLI
Denali Therapeutics Inc. Healthcare
SDGR
Schrodinger, Inc. Healthcare
NT

Nancy Thornberry

Director
New York, NY

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX